METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15253279

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods of inhibiting TIE2 kinase useful in the treatment of tumor growth, invasiveness, intravasation, dissemination, metastasis, and immunosuppression. Specifically, the invention relates to methods of using 1-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea and salts thereof of Formula I.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DECIPHERA PHARMACEUTICALS LLC200 SMITH STREET WALTHAM MA 02451

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Flynn, Daniel L Lawrence, US 173 4670
Kaufman, Michael D Lawrence, US 71 1964
Rudoltz, Marc West Orange, US 3 143
Smith, Brian D Lawrence, US 41 651

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation